185 related articles for article (PubMed ID: 30131848)
1. Increased HSF1 expression predicts shorter disease-specific survival of prostate cancer patients following radical prostatectomy.
Björk JK; Ahonen I; Mirtti T; Erickson A; Rannikko A; Bützow A; Nordling S; Lundin J; Lundin M; Sistonen L; Nees M; Åkerfelt M
Oncotarget; 2018 Jul; 9(58):31200-31213. PubMed ID: 30131848
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of heat shock factor 1 (HSF1) is associated with poor survival in gastric cancer patients.
Dai W; Ye J; Zhang Z; Yang L; Ren H; Wu H; Chen J; Ma J; Zhai E; Cai S; He Y
Diagn Pathol; 2018 Oct; 13(1):80. PubMed ID: 30326922
[TBL] [Abstract][Full Text] [Related]
3. Loss of PTEN expression in ERG-negative prostate cancer predicts secondary therapies and leads to shorter disease-specific survival time after radical prostatectomy.
Lahdensuo K; Erickson A; Saarinen I; Seikkula H; Lundin J; Lundin M; Nordling S; Bützow A; Vasarainen H; Boström PJ; Taimen P; Rannikko A; Mirtti T
Mod Pathol; 2016 Dec; 29(12):1565-1574. PubMed ID: 27562498
[TBL] [Abstract][Full Text] [Related]
4. Validation of Cyclic Adenosine Monophosphate Phosphodiesterase-4D7 for its Independent Contribution to Risk Stratification in a Prostate Cancer Patient Cohort with Longitudinal Biological Outcomes.
Alves de Inda M; van Strijp D; den Biezen-Timmermans E; van Brussel A; Wrobel J; van Zon H; Vos P; Baillie GS; Tennstedt P; Schlomm T; Houslay MD; Bangma C; Hoffmann R
Eur Urol Focus; 2018 Apr; 4(3):376-384. PubMed ID: 28753810
[TBL] [Abstract][Full Text] [Related]
5. Heat Shock Factor 1 in Relation to Tumor Angiogenesis and Disease Progression in Patients With Pancreatic Cancer.
Lin Q; Xiao G; Wang G; He Q; Xu L; Qiu P; Tan S; Gong M; Wen J; Xiao X
Pancreas; 2020; 49(10):1327-1334. PubMed ID: 33122521
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of HSF1 in estrogen receptor positive breast cancer.
Gökmen-Polar Y; Badve S
Oncotarget; 2016 Dec; 7(51):84239-84245. PubMed ID: 27713164
[TBL] [Abstract][Full Text] [Related]
7. Tissue-based Genomics Augments Post-prostatectomy Risk Stratification in a Natural History Cohort of Intermediate- and High-Risk Men.
Ross AE; Johnson MH; Yousefi K; Davicioni E; Netto GJ; Marchionni L; Fedor HL; Glavaris S; Choeurng V; Buerki C; Erho N; Lam LL; Humphreys EB; Faraj S; Bezerra SM; Han M; Partin AW; Trock BJ; Schaeffer EM
Eur Urol; 2016 Jan; 69(1):157-65. PubMed ID: 26058959
[TBL] [Abstract][Full Text] [Related]
8. Combined value of validated clinical and genomic risk stratification tools for predicting prostate cancer mortality in a high-risk prostatectomy cohort.
Cooperberg MR; Davicioni E; Crisan A; Jenkins RB; Ghadessi M; Karnes RJ
Eur Urol; 2015 Feb; 67(2):326-33. PubMed ID: 24998118
[TBL] [Abstract][Full Text] [Related]
9. Validation of the prognostic value of NF-κB p65 in prostate cancer: A retrospective study using a large multi-institutional cohort of the Canadian Prostate Cancer Biomarker Network.
Grosset AA; Ouellet V; Caron C; Fragoso G; Barrès V; Delvoye N; Latour M; Aprikian A; Bergeron A; Chevalier S; Fazli L; Fleshner N; Gleave M; Karakiewicz P; Lacombe L; Lattouf JB; van der Kwast T; Trudel D; Mes-Masson AM; Saad F;
PLoS Med; 2019 Jul; 16(7):e1002847. PubMed ID: 31265453
[TBL] [Abstract][Full Text] [Related]
10. Targeting therapy-resistant prostate cancer via a direct inhibitor of the human heat shock transcription factor 1.
Dong B; Jaeger AM; Hughes PF; Loiselle DR; Hauck JS; Fu Y; Haystead TA; Huang J; Thiele DJ
Sci Transl Med; 2020 Dec; 12(574):. PubMed ID: 33328331
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of Nuclear Heat Shock Factor 1 Contributes to Tumor Angiogenesis and Poor Survival in Patients With Non-Small Cell Lung Cancer.
Cui J; Tian H; Chen G
Ann Thorac Surg; 2015 Aug; 100(2):465-72. PubMed ID: 26095102
[TBL] [Abstract][Full Text] [Related]
12. Australian validation of the Cancer of the Prostate Risk Assessment Post-Surgical score to predict biochemical recurrence after radical prostatectomy.
Beckmann K; O'Callaghan M; Vincent A; Roder D; Millar J; Evans S; McNeil J; Moretti K
ANZ J Surg; 2018 Mar; 88(3):E183-E188. PubMed ID: 28471003
[TBL] [Abstract][Full Text] [Related]
13. Validity of the CAPRA score to predict biochemical recurrence-free survival after radical prostatectomy. Results from a european multicenter survey of 1,296 patients.
May M; Knoll N; Siegsmund M; Fahlenkamp D; Vogler H; Hoschke B; Gralla O
J Urol; 2007 Nov; 178(5):1957-62; discussion 1962. PubMed ID: 17868719
[TBL] [Abstract][Full Text] [Related]
14. Presence of cells in the polyaneuploid cancer cell (PACC) state predicts the risk of recurrence in prostate cancer.
Trabzonlu L; Pienta KJ; Trock BJ; De Marzo AM; Amend SR
Prostate; 2023 Feb; 83(3):277-285. PubMed ID: 36372998
[TBL] [Abstract][Full Text] [Related]
15. Expression of major heat shock proteins in prostate cancer: correlation with clinicopathological outcomes in patients undergoing radical prostatectomy.
Kurahashi T; Miyake H; Hara I; Fujisawa M
J Urol; 2007 Feb; 177(2):757-61. PubMed ID: 17222676
[TBL] [Abstract][Full Text] [Related]
16. A genomic classifier improves prediction of metastatic disease within 5 years after surgery in node-negative high-risk prostate cancer patients managed by radical prostatectomy without adjuvant therapy.
Klein EA; Yousefi K; Haddad Z; Choeurng V; Buerki C; Stephenson AJ; Li J; Kattan MW; Magi-Galluzzi C; Davicioni E
Eur Urol; 2015 Apr; 67(4):778-86. PubMed ID: 25466945
[TBL] [Abstract][Full Text] [Related]
17. Heat Shock Factor 1 Predicts Poor Prognosis of Gastric Cancer.
Kim SJ; Lee SC; Kang HG; Gim J; Lee KH; Lee SH; Chun KH
Yonsei Med J; 2018 Nov; 59(9):1041-1048. PubMed ID: 30328318
[TBL] [Abstract][Full Text] [Related]
18. High levels of nuclear heat-shock factor 1 (HSF1) are associated with poor prognosis in breast cancer.
Santagata S; Hu R; Lin NU; Mendillo ML; Collins LC; Hankinson SE; Schnitt SJ; Whitesell L; Tamimi RM; Lindquist S; Ince TA
Proc Natl Acad Sci U S A; 2011 Nov; 108(45):18378-83. PubMed ID: 22042860
[TBL] [Abstract][Full Text] [Related]
19. Anti-Müllerian hormone: a novel biomarker for aggressive prostate cancer? Emerging evidence from a prospective study of radical prostatectomies.
Kontogiannis S; Markantes G; Stamou M; Tsagkarakis M; Mamali I; Giannitsas K; Perimenis P; Georgopoulos N; Athanasopoulos A
Hormones (Athens); 2023 Dec; ():. PubMed ID: 38127275
[TBL] [Abstract][Full Text] [Related]
20. The inflammation-related biomarker CXCR7 independently predicts patient outcome after radical prostatectomy.
Bargão Santos P; Lobo J; Félix A; Silva F; Manso RT; Costa JO; Lourenço B; Sequeira JP; Jerónimo C; Patel HHR; Henrique R
Urol Oncol; 2020 Oct; 38(10):794.e17-794.e27. PubMed ID: 32278731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
